Literature DB >> 3281774

Association of pain relief with drug side effects in postherpetic neuralgia: a single-dose study of clonidine, codeine, ibuprofen, and placebo.

M B Max1, S C Schafer, M Culnane, R Dubner, R H Gracely.   

Abstract

In a randomized, double-blind crossover study, 40 patients with postherpetic neuralgia were given single oral doses of clonidine, 0.2 mg, codeine, 120 mg, ibuprofen, 800 mg, or inert placebo. Pain relief and side effects were recorded for 6 hours. Patients reported significantly more relief after clonidine than after the other three treatments. Codeine and ibuprofen were ineffective. Sedation, dizziness, and other side effects were more frequent after clonidine (74%) or codeine (69%) than after placebo (36%) or ibuprofen (28%). Reported pain relief was greater during trials in which side effects were present. A single, mild side effect was associated with as much additional pain relief as multiple, severe side effects. Clonidine's superiority to codeine, which had a similar incidence of side effects, argues for a specific analgesic effect. In addition, side effects may have contributed to clonidine analgesia, perhaps by suggesting to patients that they had received a potent drug.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3281774     DOI: 10.1038/clpt.1988.44

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  28 in total

1.  Economic impact of shifting the locus of care for neuropathic pain from specialists to general practitioners.

Authors:  Ariel Berger; Piotr Kramarz; Gry Stine Kopperud; John Edelsberg; Gerry Oster
Journal:  Eur J Health Econ       Date:  2007-01-13

Review 2.  Strategies for the treatment of cancer pain in the new millennium.

Authors:  C Ripamonti; E D Dickerson
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Placebo improves pleasure and pain through opposite modulation of sensory processing.

Authors:  Dan-Mikael Ellingsen; Johan Wessberg; Marie Eikemo; Jaquette Liljencrantz; Tor Endestad; Håkan Olausson; Siri Leknes
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-14       Impact factor: 11.205

4.  Use of tricyclic antidepressants in older patients with painful neuropathies.

Authors:  Ariel Berger; Ellen M Dukes; John Edelsberg; Brett R Stacey; Gerry Oster
Journal:  Eur J Clin Pharmacol       Date:  2006-06-27       Impact factor: 2.953

Review 5.  Neuropathic pain: a practical guide for the clinician.

Authors:  Ian Gilron; C Peter N Watson; Catherine M Cahill; Dwight E Moulin
Journal:  CMAJ       Date:  2006-08-01       Impact factor: 8.262

6.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.

Authors:  Paul A Carpenter; Carrie L Kitko; Sharon Elad; Mary E D Flowers; Juan C Gea-Banacloche; Jörg P Halter; Flora Hoodin; Laura Johnston; Anita Lawitschka; George B McDonald; Anthony W Opipari; Bipin N Savani; Kirk R Schultz; Sean R Smith; Karen L Syrjala; Nathaniel Treister; Georgia B Vogelsang; Kirsten M Williams; Steven Z Pavletic; Paul J Martin; Stephanie J Lee; Daniel R Couriel
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-31       Impact factor: 5.742

Review 7.  Pharmacotherapy of painful diabetic neuropathy.

Authors:  Richard Barbano; Stephanie Hart-Gouleau; Janet Pennella-Vaughan; Robert H Dworkin
Journal:  Curr Pain Headache Rep       Date:  2003-06

8.  [Pain therapy in herpes zoster and post-zoster neuralgia.].

Authors:  T Zenz; M Zenz; M Tryba
Journal:  Schmerz       Date:  1994-03       Impact factor: 1.107

9.  [Pharmacotherapy of cancer pain. 3. Adjuvant drugs.].

Authors:  N I Cherny; R K Portenoy; M Raber; M Zenz
Journal:  Schmerz       Date:  1995-03       Impact factor: 1.107

10.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.